White-coat hypertension is a risk factor for cardiovascular diseases and totalmortality

Journal of Hypertension

Volumn 35, Issue 4, 2017, Pages 677-688

  Huang, Yuli ^a   Huang, Weijun ^a   Mai, Weiyi ^b   Cai, Xiaoyan ^a   An, Dongqi ^a   Liu, Zhuheng ^a   Huang, He ^c   Zeng, Jianping ^c   Hu, Yunzhao ^a   Xu, Dingli ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c Central Hospital of Xiangtan   (China)

Author keywords

Cardiovascular diseases; Mortality; White coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ALL CAUSE MORTALITY; ANTIHYPERTENSIVE THERAPY; BIBLIOGRAPHIC DATABASE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CINAHL; COHORT ANALYSIS; DATA SYNTHESIS; DISEASE ASSOCIATION; EMBASE; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; REGRESSION ANALYSIS; REVIEW; RISK FACTOR; SCOPUS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; WHITE COAT HYPERTENSION; ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; WHITE COAT HYPERTENSION;

EID: 85020272570     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001226     Document Type: Review

References (45)

1. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34:2159-2219.
2. Franklin SS, Thijs L, Hansen TW, O'Brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension 2013; 62:982-987.
3. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005; 18:1422-1428.
4. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
5. Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: Analysis from the Dallas Heart Study. J Am Coll Cardiol 2015; 66:2159-2169.
6. Mancia G, Bombelli M, Brambilla G, Facchetti R, Sega R, Toso E, Grassi G. Long-Term prognostic value of white coat hypertension: An insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension 2013; 62:168-174.
7. Hansen TW, Kikuya M, Thijs L, Björklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: A meta-Analysis of 7, 030 individuals. J Hypertens 2007; 25:1554-1564.
8. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
9. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001; 38:238-245.
10. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005; 19:801-807.
11. Pierdomenico SD, Lapenna D, Di Mascio R, Cuccurullo F. Short-And long-Term risk of cardiovascular events in white-coat hypertension. J Hum Hypertens 2008; 22:408-414.
12. Sung SH, Cheng HM, Wang KL, Yu WC, Chuang SY, Ting CT, et al. White coat hypertension is more risky than prehypertension: important role of arterial wave reflections. Hypertension 2013; 61:1346-1353.
13. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: A meta-Analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension 2012; 59:564-571.
14. Asayama K, Thijs L, Li Y, Gu YM, Hara A, Liu YP, et al. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension 2014; 64:935-942.
15. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-Analysis of observational studies in epidemiology: A proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-2012.
16. Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-Analysis. BMJ 2016; 355:i5953.
17. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: A review of the process. Am J Prev Med 2001; 20 (3 Suppl):21-35.
18. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B. Low glomerular filtration rate and risk of stroke: meta-Analysis. BMJ 2010; 341:c4249.
19. Huang Y, Cai X, Li Y, Su L, Mai W, Wang S, et al. Prehypertension and the risk of stroke: A meta-Analysis. Neurology 2014; 82:1153-1161.
20. Huang Y, Cai X, Zhang J, Mai W, Wang S, Hu Y, et al. Prehypertension and incidence of ESRD: A systematic review and meta-Analysis. Am J Kidney Dis 2014; 63:76-83.
21. Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension 2014; 63:675-682.
22. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short-And long-Term incidence of stroke in white-coat hypertension. Hypertension 2005; 45:203-208.
23. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Sleep-Time blood pressure and the prognostic value of isolated-office and masked hypertension. Am J Hypertens 2012; 25:297-305.
24. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: An updated meta analysis. Am J Hypertens 2011; 24:52-58.
25. Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D. White-coat hypertension and cardiovascular events: A meta-Analysis. J Hypertens 2016; 34:593-599.
26. Kollias A, Ntineri A, Stergiou GS. Is white-coat hypertension a harbinger of increased risk? Hypertens Res 2014; 37:791-795.
27. Mancia G, Bombelli M, Seravalle G, Grassi G. Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol 2011; 8:686-693.
28. Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: A systematic review and meta-Analysis. J Hypertens 2008; 26:1290-1299.
29. Hosaka M, Mimura A, Asayama K, Ohkubo T, Hayashi K, Kikuya M, et al. Relationship of dysregulation of glucose metabolism with whitecoat hypertension: The Ohasama study. Hypertens Res 2010; 33:937-943.
30. Zhou J, Liu C, Shan P, Zhou Y, Xu E, Ji Y. Characteristics of white coat hypertension in Chinese Han patients with type 2 diabetes mellitus. Clin Exp Hypertens 2014; 36:321-325.
31. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-To-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57:160-166.
32. Terracciano A, Scuteri A, Strait J, Sutin AR, Meirelles O, Marongiu M, et al. Are personality traits associated with white-coat and masked hypertension? J Hypertens 2014; 32:1987-1992; 1992.
33. Jokela M, Batty GD, Nyberg ST, Virtanen M, Nabi H, Singh-Manoux A, Kivimäki M. Personality and all-cause mortality: individual-participant meta-Analysis of 3, 947 deaths in 76, 150 adults. Am J Epidemiol 2013; 178:667-675.
34. Andrikou I, Tsioufis C, Dimitriadis K, Syrseloudis D, Valenti P, Almiroudi M, et al. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension. Blood Press Monit 2011; 16:218-223.
35. Grassi G, Seravalle G, Trevano FQ, Dell'oro R, Bolla G, Cuspidi C, et al. Neurogenic abnormalities in masked hypertension. Hypertension 2007; 50:537-542.
36. Curgunlu A, Uzun H, Bavunoglu I, Karter Y, Genc H, Vehid S. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J Hum Hypertens 2005; 19:629-633.
37. Yavuzer S, Yavuzer H, Cengiz M, Erman H, Altiparmak MR, Korkmazer B, et al. Endothelial damage in white coat hypertension: role of lectinlike oxidized low-density lipoprotein-1. J Hum Hypertens 2015; 29:92-98.
38. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31:1731-1768.
39. Nasothimiou EG, Tzamouranis D, Rarra V, Roussias LG, Stergiou GS. Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension. Hypertens Res 2012; 35:750-755.
40. Cloutier L, Daskalopoulou SS, Padwal RS, Lamarre-Cliche M, Bolli P, McLean D, et al. A new algorithm for the diagnosis of hypertension in Canada. Can J Cardiol 2015; 31:620-630.
41. Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis and treatment of hypertension: A systematic review. Am J Hypertens 2011; 24:123-134.
42. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: A joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 2008; 52:1-9.
43. Mancia G, Facchetti R, Parati G, Zanchetti A. Effect of long-Term antihypertensive treatment on white-coat hypertension. Hypertension 2014; 64:1388-1398.
44. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000; 102:1139-1144.
45. Bulpitt CJ, Beckett N, Peters R, Staessen JA, Wang JG, Comsa M, et al. Does white coat hypertension require treatment over age 80?: results of the Hypertension in the Very Elderly Trial ambulatory blood pressure side project. Hypertension 2013; 61:89-94.